ghk-cu desensitization or tolerance mechanism of action ghk cu Evaluating the stability and safety encapsulated in an OBM Geriatrics ghk-cu tolerance ghk-cu tolerance desensitization evidence The

10.1254/jphs.fp0061322 29 DrmicD.SamaraM.VidovicT.MalekinusicD.AntunovicM.VrdoljakB.et al (2018)

36 studies reviewed (1993-2024) Mechanism: NO system modulation, VEGF/angiogenesis, FAK-paxillin migration pathway Clinical Status: Not FDA or EMA approved

A: Same BPC-157 supply (3-9 vials)

It's not enough to supply a high-quality peptide like our Ghk-cu Copper Peptide

These compounds are known to have significant adverse effects on human health as exposure, particularly developmental exposure, has been associated with cognitive deficits, neurological disorders, reproductive abnormalities, metabolic diseases/disorders, obesity, and diabetes 5

A Higher Standard of Liposomal Delivery with QDS The Quicksilver Delivery Systems signature trademark sets our liposomal products apart from other companies and ensures high absorption and bioavailability